Demographic Patterns and Treatment Outcomes of Patients With Recurrent Corneal Erosions Related to Trauma and Epithelial and Bowman Layer Disorders

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Demographic Patterns and Treatment Outcomes of Patients With Recurrent Corneal Erosions Related to Trauma and Epithelial and Bowman Layer Disorders

Purpose To evaluate demographics and outcomes of patients with recurrent corneal erosions related to trauma and epithelial and Bowman layer disorders. Design Retrospective case series. Methods setting : Wills Eye…

read more

Reply

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We appreciate the interest and comments on our article. The spectral-domain optical coherence tomography (SD OCT) scan image from a 64-year-old woman in Figure 2 might be similar to adult-onset vitelliform…

read more

Parallelism as a Novel Marker for Structural Integrity of Retinal Layers in Optical Coherence Tomographic Images in Eyes With Epiretinal Membrane

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Parallelism as a Novel Marker for Structural Integrity of Retinal Layers in Optical Coherence Tomographic Images in Eyes With Epiretinal Membrane

Purpose To propose a new parameter, “Parallelism,” to evaluate retinal layer integrity on spectral-domain optical coherence tomography (SDOCT), and to investigate the association between parallelism and visual function in eyes…

read more

Reply

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We appreciate Dr Kishore’s interest in our recently published manuscript. He questioned the use of bevacizumab (1.25 mg/0.05 mL; Avastin; Genentech Inc, San Francisco, California, USA) for the treatment of…

read more

Randomized Controlled Trial of Intravitreal Ranibizumab Versus Standard Grid Laser for Macular Edema Following Branch Retinal Vein Occlusion

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Randomized Controlled Trial of Intravitreal Ranibizumab Versus Standard Grid Laser for Macular Edema Following Branch Retinal Vein Occlusion

Purpose To assess the efficacy of intravitreal 0.5 mg ranibizumab for the treatment of center-involving macular edema secondary to branch retinal vein occlusion (BRVO) over 1 year compared with standard-of-care grid…

read more
Get Clinical Tree app for offline access